Home NDC 68462-140-01 Meloxicam
Product NDC 68462-140
Requested package NDC 68462-140-01
11-digit product format 684620140
Labeler code 68462
Product ID 68462-140_1bfddea3-c305-4688-978d-36c882261be7
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Meloxicam
Dosage form TABLET
Route ORAL
Labeler Glenmark Pharmaceuticals Inc., USA
Application ANDA077932
Marketing category ANDA
Marketing start 2021-06-01
Marketing end 0000-00-00
Substance MELOXICAM
Active strength 8 mg/1
Pharmacologic classes Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68462-140 68462-140-01 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68462-140 68462-140-01 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077932-001 MELOXICAM MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 A077932-002 MELOXICAM MELOXICAM 15MG TABLET / ORAL AB 2006-07-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 84e616aacf4f…2026-08-18 06:07:40 2026-07 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A077932-001 MELOXICAM 7.5MG TABLET / ORAL AB 2006-07-19 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A077932-002 MELOXICAM 15MG TABLET / ORAL AB 2006-07-19 74a2ff9319b5…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 86 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MELOXICAM ACTIVE INGREDIENT VG2QF83CGL MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5 MELOXICAM ACTIVE MOIETY VG2QF83CGL MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5 POVIDONES INACTIVE INGREDIENT FZ989GH94E MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5 TRISODIUM CITRATE DIHYDRATE INACTIVE INGREDIENT B22547B95K MELOXICAM TABLET [GLENMARK GENERICS INC., USA] 5
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68462-140-01 68462014001 100 TABLET in 1 BOTTLE (68462-140-01) 100 tablet 2021-06-01 0000-00-00 No No Current